| 000 | nam a22 a 4500 | ||
|---|---|---|---|
| 999 |
_c23273 _d23273 |
||
| 001 | BD-DhNSU-23273 | ||
| 003 | BD-DhNSU | ||
| 005 | 20190403070715.0 | ||
| 008 | 190403s2004 nyua|||g |||| 001 0|eng d | ||
| 010 | _a | ||
| 020 | _a9780443072406 | ||
| 040 |
_aDLC _cDLC _dBD-DhNSU |
||
| 041 | _aeng | ||
| 050 | 0 | 0 |
_aRS100 _b.P43 2004 |
| 245 | 0 | 0 |
_aPharmacoeconomics / _cedited by Tom Walley, Alan Haycox and Angela Boland |
| 260 |
_aNew York : _bChurchill Livingstone, _cc2004. |
||
| 300 |
_axii, 203 p. : _bill. ; _c24 cm. |
||
| 650 | 0 | _aDrugs | |
| 650 | 4 | _aCost effectiveness | |
| 650 | 4 | _aPharmaceutical industry | |
| 700 | 1 | _aWalley, Tom | |
| 700 | 1 | _aHaycox, Alan | |
| 700 | 1 | _aBoland, Angela | |
| 942 |
_2lcc _cBK |
||